Christopher Cabell

Affiliations

  • President & Head Of R&D at Inhibikase Therapeutics Inc. (IKT), 2025-02-25
  • Cmo & Head Of R&D at Zura Bio Ltd (ZURA), 2023-05-23
  • Director at Pulmatrix Inc. (PULM), 2023-01-30
  • Evp, Head Of R&D, And Cmo at Arena Pharmaceuticals Inc (ARNA), 2020-11-30
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ARNA $68.00 13,000 Officer 0 2020-07-15 Filing